3Suppliers
12Customers
2Debt Items
20Related Chains

Source-Backed Evidence Depth

Artivion, Inc. (AORT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

18Total relationships
2Distinct source URLs
3High confidence
0.717Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Artivion, Inc. Suppliers

TickerNameConfidenceEvidence
ABT Abbott Laboratories 72% Reciprocal relationship from ABT graph: Reciprocal relationship from AORT graph: Reciprocal relationship from ABT graph: Reciprocal relationship from AORT graph: Reciprocal relationship from ABT grap…
BDX Becton, Dickinson and Company 72% Reciprocal relationship from BDX graph: Reciprocal relationship from AORT graph: Reciprocal relationship from BDX graph: Reciprocal relationship from AORT graph: Reciprocal relationship from BDX grap…
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from AORT graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from AORT graph: Reciprocal relationship from JNJ grap…

Artivion, Inc. Customers

TickerNameConfidenceEvidence
ABT Abbott Laboratories 72% Reciprocal relationship from ABT graph: Reciprocal relationship from AORT graph: r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operati…
ABT Abbott Laboratories 72% r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operations and supply chain disruptions as a result, including disruptions related to sh…
BDX Becton, Dickinson and Company 72% Reciprocal relationship from BDX graph: Reciprocal relationship from AORT graph: r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operati…
BDX Becton, Dickinson and Company 72% r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operations and supply chain disruptions as a result, including disruptions related to sh…
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from AORT graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from AORT graph: r in Iran; however, it is difficult t…
JNJ Johnson & Johnson 72% r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operations and supply chain disruptions as a result, including disruptions related to sh…
BAX Baxter International Inc. 62% Reciprocal relationship from BAX graph: Reciprocal relationship from AORT graph: . Significant Accounting Policies A summary of our significant accounting policies is included in Note 1 of the “Notes…
BAXTER-INTERNATIONAL-INC BAXTER-INTERNATIONAL-INC 62% . Significant Accounting Policies A summary of our significant accounting policies is included in Note 1 of the “Notes to Consolidated Financial Statements” contained in our Form 10-K for the year en…
COMPANY-INTEGRA-LIFE-SCIENCES-LIFENET-HEALTH-COR COMPANY-INTEGRA-LIFE-SCIENCES-LIFENET-HEALTH-COR 62% r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operations and supply chain disruptions as a result, including disruptions related to sh…
GRENA-LIMITED GRENA-LIMITED 62% r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operations and supply chain disruptions as a result, including disruptions related to sh…
JOTEC-GMBH-ON-X-LIFE-TECHNOLOGIES-INC-HEMOSPHERE JOTEC-GMBH-ON-X-LIFE-TECHNOLOGIES-INC-HEMOSPHERE 62% about the timing and results of our clinical trials, approvals, and product commercialization and launches; • Our expectations related to anticipated expansion of our business and the sufficiency of …
STARCH-MEDICAL-INC STARCH-MEDICAL-INC 62% . Significant Accounting Policies A summary of our significant accounting policies is included in Note 1 of the “Notes to Consolidated Financial Statements” contained in our Form 10-K for the year en…

Artivion, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
AORT-DEBT Debt stack $363.4M 90% Market cache reports total debt of $363.4M.
AORT-DEBT-7781 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.

Artivion, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Artivion, Inc..

Artivion, Inc. Ownership

HolderNameConfidenceEvidence
AORT-OWNER-MORGAN-STANLEY MORGAN STANLEY 90% 13F overlay lists MORGAN STANLEY as top holder; 240 tracked holders.

Artivion, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ATRA Atara Biotherapeutics, Inc. 100.00 2
ADGM Adagio Medical Holdings, Inc. 100.00 2
CSTE Caesarstone Ltd. 100.00 2
GCTK GlucoTrack, Inc. 100.00 2
ANGO AngioDynamics, Inc. 100.00 2
BCAX Bicara Therapeutics Inc. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
SNNUF Smith & Nephew plc 100.00 2
ALC Alcon Inc. 100.00 2
BLLN BillionToOne, Inc. 100.00 2
BAX Baxter International Inc. 100.00 1 ['customer']
BDX Becton, Dickinson and Company 100.00 1 ['customer', 'supplier']
CLGN CollPlant Biotechnologies Ltd. 100.00 2
GRAL GRAIL, Inc. 100.00 2
BNR Burning Rock Biotech Limited 100.00 2
ALVO Alvotech 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
ABBV AbbVie Inc. 100.00 2
🔐
AORT
Unlock AORT Supply Chain Data
Verified relationships include:
ABTAbbott LaboratoriesSupplier72%
BDXBecton, Dickinson and CompanySupplier72%
ABTAbbott LaboratoriesCustomer72%
ABTAbbott LaboratoriesCustomer72%
+14 more relationships locked
Subscribe, View plans →